Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs
Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with the threat of drug import duties from the Trump administration.
Eli Lilly has unveiled a $27 billion (€25.7 billion) investment in US manufacturing facilities as the pharmaceutical industry ...
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
GAINS in Nvidia ahead of earnings helped lift the Nasdaq on Wednesday while the Dow retreated on White House talk of more ...
Key Takeaways Eli Lilly plans to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback